These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20660105

  • 1. Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo.
    Atchison DK, Ortiz-Capisano MC, Beierwaltes WH.
    Am J Physiol Regul Integr Comp Physiol; 2010 Oct; 299(4):R1020-6. PubMed ID: 20660105
    [Abstract] [Full Text] [Related]

  • 2. Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat.
    Maillard MP, Tedjani A, Perregaux C, Burnier M.
    J Hypertens; 2009 Oct; 27(10):1980-7. PubMed ID: 19593209
    [Abstract] [Full Text] [Related]

  • 3. Hypercalcemia reduces plasma renin via parathyroid hormone, renal interstitial calcium, and the calcium-sensing receptor.
    Atchison DK, Harding P, Beierwaltes WH.
    Hypertension; 2011 Oct; 58(4):604-10. PubMed ID: 21825222
    [Abstract] [Full Text] [Related]

  • 4. Expression and function of the calcium-sensing receptor in juxtaglomerular cells.
    Ortiz-Capisano MC, Ortiz PA, Garvin JL, Harding P, Beierwaltes WH.
    Hypertension; 2007 Oct; 50(4):737-43. PubMed ID: 17785631
    [Abstract] [Full Text] [Related]

  • 5. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
    Muller ME, Forni Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, Wuerzner G, Burnier M, Bonny O.
    Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029
    [Abstract] [Full Text] [Related]

  • 6. Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.
    Ortiz-Capisano MC, Reddy M, Mendez M, Garvin JL, Beierwaltes WH.
    Am J Physiol Renal Physiol; 2013 Feb 01; 304(3):F248-56. PubMed ID: 23220722
    [Abstract] [Full Text] [Related]

  • 7. Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells.
    Ortiz-Capisano MC, Liao TD, Ortiz PA, Beierwaltes WH.
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov 01; 297(5):R1469-76. PubMed ID: 19741056
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide and prostaglandins are involved in the macula densa control of the renin system.
    Schricker K, Hamann M, Kurtz A.
    Am J Physiol; 1995 Dec 01; 269(6 Pt 2):F825-30. PubMed ID: 8594876
    [Abstract] [Full Text] [Related]

  • 9. Comparison of AMG 416 and cinacalcet in rodent models of uremia.
    Walter S, Baruch A, Alexander ST, Janes J, Sho E, Dong J, Yin Q, Maclean D, Mendel DB, Karim F, Johnson RM.
    BMC Nephrol; 2014 May 19; 15():81. PubMed ID: 24884838
    [Abstract] [Full Text] [Related]

  • 10. Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet.
    Fryer RM, Segreti JA, Widomski DL, Franklin PH, Banfor PN, Koch KA, Nakane M, Wu-Wong JR, Cox BF, Reinhart GA.
    J Pharmacol Exp Ther; 2007 Oct 19; 323(1):217-26. PubMed ID: 17636005
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II type 2 receptor inhibits prorenin processing in juxtaglomerular cells.
    Ichihara A, Hayashi M, Hirota N, Okada H, Koura Y, Tada Y, Kaneshiro Y, Tsuganezawa H, Saruta T.
    Hypertens Res; 2003 Nov 19; 26(11):915-21. PubMed ID: 14714584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.
    Prieto-Carrasquero MC, Kobori H, Ozawa Y, Gutiérrez A, Seth D, Navar LG.
    Am J Physiol Renal Physiol; 2005 Sep 19; 289(3):F632-7. PubMed ID: 15870381
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    Finch JL, Tokumoto M, Nakamura H, Yao W, Shahnazari M, Lane N, Slatopolsky E.
    Am J Physiol Renal Physiol; 2010 Jun 19; 298(6):F1315-22. PubMed ID: 20200094
    [Abstract] [Full Text] [Related]

  • 17. Cinacalcet: pharmacological and clinical aspects.
    Messa P, Alfieri C, Brezzi B.
    Expert Opin Drug Metab Toxicol; 2008 Dec 19; 4(12):1551-60. PubMed ID: 19040330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice.
    Kim SM, Chen L, Mizel D, Huang YG, Briggs JP, Schnermann J.
    Am J Physiol Renal Physiol; 2007 Jan 19; 292(1):F415-22. PubMed ID: 16954340
    [Abstract] [Full Text] [Related]

  • 20. Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
    Kawata T, Imanishi Y, Kobayashi K, Onoda N, Okuno S, Takemoto Y, Komo T, Tahara H, Wada M, Nagano N, Ishimura E, Miki T, Ishikawa T, Inaba M, Nishizawa Y.
    J Bone Miner Metab; 2006 Jan 19; 24(4):300-6. PubMed ID: 16816924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.